Early and Late Virological Monitoring of Cytomegalovirus, Epstein-Barr Virus, and Human Herpes Virus 6 Infections in Small Bowel/Multivisceral Transplant Recipients

Transplantation Proceedings

Volumn 42, Issue 1, 2010, Pages 74-78

  Petrisli, E ^a   Chiereghin, A ^a   Gabrielli, L ^a   Zanfi, C ^a   Lauro, A ^a   Piccirilli, G ^a   Baccolini, F ^a   Altimari, A ^a   Bagni, A ^a   Cescon, M ^a   Pinna, A D ^a   Landini, M P ^a   Lazzarotto, T ^a  

^a UNIVERSITY OF BOLOGNA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ALEMTUZUMAB; CYTOMEGALOVIRUS ANTIBODY; GANCICLOVIR; RAPAMYCIN; STEROID; TACROLIMUS; THYMOCYTE ANTIBODY; VALGANCICLOVIR; VIRUS DNA;

ACUTE GRAFT REJECTION; ADD ON THERAPY; ADULT; ARTICLE; BIOPSY; BLOOD SAMPLING; CLINICAL ARTICLE; CONTROLLED STUDY; CYTOMEGALOVIRUS INFECTION; DIARRHEA; ENTERITIS; EPSTEIN BARR VIRUS; FEMALE; FEVER; GRAFT RECIPIENT; HERPES VIRUS INFECTION; HUMAN; HUMAN HERPESVIRUS 6; HUMAN TISSUE; IMMUNOSUPPRESSIVE TREATMENT; INTESTINE TRANSPLANTATION; LOW DRUG DOSE; MALE; PATIENT MONITORING; POPULATION; PRIORITY JOURNAL; PROPHYLAXIS; UNSPECIFIED SIDE EFFECT; VIROLOGY; VIRUS PNEUMONIA; VOMITING;

ADULT; BIOPSY; CYTOMEGALOVIRUS; CYTOMEGALOVIRUS INFECTIONS; DNA, VIRAL; HERPESVIRIDAE INFECTIONS; HERPESVIRUS 4, HUMAN; HERPESVIRUS 6, HUMAN; HUMANS; INTESTINE, SMALL; LUNG; ROSEOLOVIRUS INFECTIONS; VISCERA;

EID: 76749153748     PISSN: 00411345     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.transproceed.2009.12.032     Document Type: Article

References (13)

1. Abu-Elmagd K., Reyes J., Todo S., et al. Clinical intestinal transplantation: new prospectives and immunologic considerations. J Am Coll Surg 186 (1998) 512
2. Thompson J.S. Intestinal transplantation. Experience in the United States. Eur J Pediatr Surg 9 (1999) 271
3. Burroughs M., Sobanjo A., Floman S., et al. Cytomegalovirus matching does not predict symptomatic disease in intestinal transplantation. Transplant Proc 34 (2002) 946
4. Abu-Elmagd K.M., Mazariegos G., Costa G., et al. Lymphoproliferative disorders and de novo malignacies in intestinal and multivisceral recipients: improved outcomes with new outlooks. Transplantation 88 (2009) 926
5. Reyes J., Green M., Bueno J., et al. Epstein-Barr virus associated posttransplant lymphoproliferative disease after intestinal transplantation. Transplant Proc 28 (1996) 2768
6. Young L., Alfieri C., Hennessy K., et al. Expression of Epstein-Barr virus transformation-associated genes in tissues of patients with EBV lymphoproliferative disease. N Engl J Med 321 (1989) 1080
7. Younes U., McDiarmid S., Martin M., et al. The effect of immunosuppression on posttransplant lymphoproliferative disease in pediatric liver transplant patients. Transplantation 70 (2000) 94
8. Pellett P.E., and Dominguez G. Human herpes 6A, 6B, and 7. In: Fields B.N., Knipe D.M., and Howley P.M. (Eds). The Fields Virology. 4th Ed. (2001), Lippincott-Raven Publishers, Philadelphia 2769
9. De Bolle L., Naesens L., De Clercq E., et al. Update on human herpesvirus 6 biology, clinical features and therapy. Clin Microbiol Rev 18 (2005) 217
10. Kato T., Ruiz P., Thompson J.F., et al. Intestinal and multivisceral transplantation. World J Surg 26 (2002) 226
11. American Society of Transplantation Infectious Diseases Guidelines: Other herpesviruses: HHV-6, HHV-7, HHV-8, HSV-1 and-2, VZV. Am J Transplant 4 Suppl 10 (2004) 66
12. Razonable R.R., Rivero A., Brown R.A., et al. Detection of simultaneous beta-herpesvirus infections in clinical syndromes due to defined cytomegalovirus infection. Clin Transplant 17 (2003) 114
13. Cocchi S., Di Benedetto F., Codeluppi M., et al. Fatal cytomegalovirus necrotising enteritis in a small bowel transplantation adult recipient with low pp65 antigenaemia levels. Dig Liver Dis 38 (2006) 429